Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Injections, Intralymphatic”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 559 records · Page 31Linked to original sources
PubMed1981

[Endolymphatic use of solutions of alkylating substances in a mixture with iodolipol in malignant neoplasms].

The results of endolymphatic chemotherapy and lymphography in 57 cases of different malignant neoplasms in the lymphatic system are presented. Procedures for making alcohol-oil solution of benzo-TEP, ether-oil solution of tio-TEP and alcohol-oil emulsion of cyclophosphamide are discussed and the clinical evaluation of the results of their application is given. The therapeutic effect of endolymphatic infusions of the mixtures of alkylating agents and iodolipol was assessed on the basis of clinical, histological and radiological examination of malignant lesions of lymph nodes. It is shown that the efficacy of endolymphatic chemotherapy is determined by the susceptibility of neoplasms to antitumor drugs and the availability of the latter at lymph node metastases.

Alkylating Agents↗
PubMedDate not supplied

[Effect of the endolymphatic administration of protease inhibitors on pancreatic morphofunctional activity in acute experimental pancreatitis].

Experimental acute pancreatitis was induced in 16 dogs by administering infected bile under pressure. Functional and electron microscopic changes in the pancreas were studied before and after endolymphatic infusions of contrykal in a dose of 10 000 ATpE. It was established that endolymphatic administration of contrykal leads to an appreciable decrease in proteolytic activity of the pancreas and to inactivation of the kallikrein-kinin system. Electron microscopy studies of the exocrine apparatus of the pancreas after the dogs' death have demonstrated that endolymphatic administration of contrykal reduces intracellular processes of the synthesis of pancreatic enzymes.

Acute Disease↗
PubMed1982

[Experimental study of the endolymphatic use of gentamycin and klaforan (cefotaxime)].

Distribution of gentamycin and klaforan in the lymphatic system, blood and cerebrospinal fluid, as well as their effect on lymph node morphology was studied experimentally on 46 dogs. The antibiotics were administered endolymphatically in doses of 1 and 30 mg/kg respectively. The highest levels of gentamycin (200-250 micrograms/ml) and klaforan (up to 1600 micrograms/ml) were detected in the central lymph. The therapeutic levels of the antibiotics in the central persisted for 24 and 72 hours respectively. The antibiotics accumulated mainly in the regional (inguinal and pelvic) lymph nodes, where their high levels were determined for 72 hours. The levels of the antibiotics in the distant (cervical and tracheobronchial) lymph nodes were lower and did not exceed the therapeutic ones. They persisted for 6 and 24 hours respectively. No unfavourable effect of the antibiotics on the structure and cell composition of the lymph nodes was noted. After endolymphatic administration in the above doses the antibiotic levels in the blood serum were close to those observed after administration by the routine routes. After endolymphatic administration in the above doses the antibiotics penetrated into the cerebrospinal fluid.

Animals↗
PubMed1982

[Clinico-laboratory basis for the endolymphatic use of beta-lactam antibiotics in pulmonology].

Clinical efficacy and effect of cefuroxime, claforan and pentrexyl used endolymphatically were studied in 85 patients with acute abscess forming and persisting pneumonia. Previous routine antibiotic therapy in these patients was little effective. Administration of the antibiotics into the peripheral lymph nodes provided blocking of the lymphagenic pathway for the infection due to high levels in the lymphatic system. Endolymphatic use of cefuroxime and claforan resulted in a significant improvement of the functions of the T- and B-immunity systems and the indices of natural resistance. The levels of the autoimmune reactions and sensitization to the bacterial antigens decreased. Endolymphatic use of cefuroxime and claforan once every 3 days provided recovery of 9 2.8 per cent of the patients, the treatment periods being decreased 2.5--3 times. Intravenous administration of the drugs according to the routine schemes, endolymphatic use of pentrexyl (5 g once every 3 days) and endolymphatic administration of cefuroxime in a single dose followed by intravenous therapy was less effective. The efficacy of pentrexyl increased, when it was used endolymphatically in combination with lysozyme. Endolymphatic use of claforan in doses of 2--3 g once every 3 days (3--4 infusions during the treatment course) was most effective.

Adult↗